BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

803 related articles for article (PubMed ID: 24846652)

  • 1. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses.
    Gauvreau GM; O'Byrne PM; Boulet LP; Wang Y; Cockcroft D; Bigler J; FitzGerald JM; Boedigheimer M; Davis BE; Dias C; Gorski KS; Smith L; Bautista E; Comeau MR; Leigh R; Parnes JR
    N Engl J Med; 2014 May; 370(22):2102-10. PubMed ID: 24846652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma.
    Gauvreau GM; Hohlfeld JM; FitzGerald JM; Boulet LP; Cockcroft DW; Davis BE; Korn S; Kornmann O; Leigh R; Mayers I; Watz H; Grant SS; Jain M; Cabanski M; Pertel PE; Jones I; Lecot JR; Cao H; O'Byrne PM
    Eur Respir J; 2023 Mar; 61(3):. PubMed ID: 36822634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OX40L blockade and allergen-induced airway responses in subjects with mild asthma.
    Gauvreau GM; Boulet LP; Cockcroft DW; FitzGerald JM; Mayers I; Carlsten C; Laviolette M; Killian KJ; Davis BE; Larché M; Kipling C; Dua B; Mosesova S; Putnam W; Zheng Y; Scheerens H; McClintock D; Matthews JG; O'Byrne PM
    Clin Exp Allergy; 2014 Jan; 44(1):29-37. PubMed ID: 24224471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymic stromal lymphopoietin activation of basophils in patients with allergic asthma is IL-3 dependent.
    Salter BM; Oliveria JP; Nusca G; Smith SG; Watson RM; Comeau M; Sehmi R; Gauvreau GM
    J Allergy Clin Immunol; 2015 Dec; 136(6):1636-1644. PubMed ID: 25962901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal GSK2245035, a Toll-like receptor 7 agonist, does not attenuate the allergen-induced asthmatic response in a randomized, double-blind, placebo-controlled experimental medicine study.
    Siddall H; Quint D; Pandya H; Powley W; Shabbir S; Hohlfeld JM; Singh D; Lee L
    PLoS One; 2020; 15(11):e0240964. PubMed ID: 33166307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma.
    Smith SG; Gugilla A; Mukherjee M; Merim K; Irshad A; Tang W; Kinoshita T; Watson B; Oliveria JP; Comeau M; O'Byrne PM; Gauvreau GM; Sehmi R
    J Allergy Clin Immunol; 2015 Jun; 135(6):1594-602. PubMed ID: 25656998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
    Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S
    J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bimosiamose, an inhaled small-molecule pan-selectin antagonist, attenuates late asthmatic reactions following allergen challenge in mild asthmatics: a randomized, double-blind, placebo-controlled clinical cross-over-trial.
    Beeh KM; Beier J; Meyer M; Buhl R; Zahlten R; Wolff G
    Pulm Pharmacol Ther; 2006; 19(4):233-41. PubMed ID: 16140027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme.
    Krug N; Hohlfeld JM; Kirsten AM; Kornmann O; Beeh KM; Kappeler D; Korn S; Ignatenko S; Timmer W; Rogon C; Zeitvogel J; Zhang N; Bille J; Homburg U; Turowska A; Bachert C; Werfel T; Buhl R; Renz J; Garn H; Renz H
    N Engl J Med; 2015 May; 372(21):1987-95. PubMed ID: 25981191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell-mediated induction of thymic stromal lymphopoietin in differentiated human primary bronchial epithelial cells.
    Hui CC; Murphy DM; Neighbour H; Al-Sayegh M; O'Byrne S; Thong B; Denburg JA; Larché M
    Clin Exp Allergy; 2014 Jul; 44(7):953-64. PubMed ID: 24773145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers.
    Parameswaran K; Inman MD; Watson RM; Morris MM; Efthimiadis A; Ventresca PG; Lam R; O'Byrne PM; Hargreave FE
    Can Respir J; 2000; 7(4):313-9. PubMed ID: 10980457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tezepelumab in Adults with Uncontrolled Asthma.
    Corren J; Parnes JR; Wang L; Mo M; Roseti SL; Griffiths JM; van der Merwe R
    N Engl J Med; 2017 Sep; 377(10):936-946. PubMed ID: 28877011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild-to-moderate asthma.
    Leaker BR; Barnes PJ; O'Connor BJ; Ali FY; Tam P; Neville J; Mackenzie LF; MacRury T
    Clin Exp Allergy; 2014 Sep; 44(9):1146-53. PubMed ID: 25040039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ASM-024, a modulator of acetylcholine receptor function, on airway responsiveness and allergen-induced responses in patients with mild asthma.
    Boulet LP; Gauvreau GM; Cockcroft DW; Davis B; Vachon L; Cormier Y; O'Byrne PM
    Can Respir J; 2015; 22(4):230-4. PubMed ID: 26252534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma.
    Cheng DT; Ma C; Niewoehner J; Dahl M; Tsai A; Zhang J; Gonsiorek W; Apparsundaram S; Pashine A; Ravindran P; Jung J; Hang J; Allard J; Bitter H; Tribouley C; Narula S; Wilson S; Fuentes ME
    J Allergy Clin Immunol; 2013 Aug; 132(2):455-62. PubMed ID: 23810153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge.
    Scheerens H; Arron JR; Zheng Y; Putnam WS; Erickson RW; Choy DF; Harris JM; Lee J; Jarjour NN; Matthews JG
    Clin Exp Allergy; 2014 Jan; 44(1):38-46. PubMed ID: 24131304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dual CysLT
    Gauvreau GM; Boulet LP; FitzGerald JM; Cockcroft DW; Davis BE; Leigh R; Tanaka M; Fourre JA; Tanaka M; Nabata T; O'Byrne PM
    Allergy; 2016 Dec; 71(12):1721-1727. PubMed ID: 27444660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics.
    Diamant Z; Sidharta PN; Singh D; O'Connor BJ; Zuiker R; Leaker BR; Silkey M; Dingemanse J
    Clin Exp Allergy; 2014 Aug; 44(8):1044-52. PubMed ID: 24964348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.
    Leckie MJ; ten Brinke A; Khan J; Diamant Z; O'Connor BJ; Walls CM; Mathur AK; Cowley HC; Chung KF; Djukanovic R; Hansel TT; Holgate ST; Sterk PJ; Barnes PJ
    Lancet; 2000 Dec 23-30; 356(9248):2144-8. PubMed ID: 11191542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of montelukast (MK-0476), a cysteinyl leukotriene receptor antagonist, on allergen-induced airway responses and sputum cell counts in asthma.
    Diamant Z; Grootendorst DC; Veselic-Charvat M; Timmers MC; De Smet M; Leff JA; Seidenberg BC; Zwinderman AH; Peszek I; Sterk PJ
    Clin Exp Allergy; 1999 Jan; 29(1):42-51. PubMed ID: 10051701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.